spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Fifth Annual Peptides Congress: Registration Now Open

Join us at the forefront of industry innovation at the 5th Annual Peptides Congress

Join us at the forefront of industry innovation at the 5th Annual Peptides Congress, 16-17 April 2018 in London to shape the future of industry discussion. With over 700 peptides in clinical trials and an increasing industry focus on biologics, now more than ever is the time to focus on this revolutionary field!

Our industry renowned speakers will guide you through key topics such as peptide synthesis, therapeutics, delivery and discovery. Critical discussions will take place on drug conjugates, peptide-based vaccines and cyclic peptides, with a strong focus on case studies and best practice.

Key presentation areas include:

Peptide Research, Chemistry & Analytical Technologies
  • Computational & measured property trends among orally bioavailable peptides by Alan Mathiowetz, Director, Pfizer
  • Peptide purification & optimisation by Mathias Schaffrath, Group Head Chromatography, Sanofi
Peptide Therapeutics
  • Personalised peptide based-vaccines by Jesse Dong, Vice President Peptide Chemistry, Neon Therapeutics
  • Application of peptidomimetics for improved pain treatments by Steven Ballet, Professor, Free University of Brussels
Peptide Discovery, Manufacturing & Delivery
  • Challenges of alternative/ oral routes of peptides delivery by Todd Page, Director of Toxicology, Eli Lilly
  • Peptides drug delivery by Stephen Buckley, Head of Discovery ADME, Novo Nordisk
View the full line up of speakers, 30+ exhibitors and information on the new 'think tank' round table discussions here.

Peptides and Medicinal Chemistry Free Webinars

  • From Peptide Discovery to Phase 3 – A Zealand Perspective. Hosted by Andy Parker, Senior Vice President & Chief Scientific Officer, Zealand Pharma. Register for Free Today
  • Macrocycle Medicinal Chemistry Optimization – Conformation Matters. Hosted by Marc Thommen, Head of Chemistry, Polyphor. Register for Free Today
Media Contact
Guillaume Alonso
Marketing Campaign Manager
Phone: +44 (0)1865 248455
Email: g.alonso@oxfordglobal.co.uk
 
Print this page
Send to a friend
   
spacer
News and Press Releases

BioIVT Appoints Alan Findlater as Chief Commercial Officer

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has appointed Alan Findlater to the newly-created role of chief commercial officer. In his new position, Mr. Findlater will be responsible for all of BioIVT’s commercial activities, including global sales, marketing and customer service.
More info >>


White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>

Industry Events

CPhI & P-MEC India 2018

12-14 December 2018, India Expo Mart, New Delhi, India

CPhI & P-MEC India (December 12-14, 2018) – organised by UBM (part of Informa PLC) – announces that the 12th edition of Asia’s largest Pharma exhibition is moving to the India Expo Mart, New Delhi. The new venue will see the exhibition now hosted in a single venue, bringing it closer to the Indian regulatory and legislative capital. New Delhi is also the country’s main international transport hub and will encourage an increased international attendance. In total, more than 50,000 people from 122 countries are expected, along with nearly 1,500 exhibitors.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement